Market Overview:
The growth in the market can be attributed to the increasing incidence of cancer, rising demand for minimally invasive procedures, and technological advancements in diagnostic imaging modalities. Contrast media are used for enhancing images during medical procedures such as X-rays or MRIs. Contrast agents help improve image quality by making tissues easier to see by altering their appearance based on how they interact with X-rays or MRI signals. .
Product Definition:
The most common use is in x-rays, where they make it possible to see bones, muscles and other structures inside the body. Contrast media can also be used in magnetic resonance imaging (MRI) and computed tomography (CT) scans.
Radiopharmaceuticals:
Radiopharmaceutical is a combination of a pharmaceutical product and a radioisotope, which can be used to treat or diagnose certain diseases by using the radiation emitted by that radio isotope.
Contrast Media:
The contrast media market is expected to grow at a lucrative rate during the forecast period owing to increasing demand for noninvasive medical imaging techniques coupled with rising prevalence of chronic diseases such as cancer, cardiovascular disorders & diabetes.
Global Contrast Media.
Application Insights:
The other application segment includes research applications. The growing usage of these products in various research activities such as cell proliferation, cell migration and tumor angiogenesis is expected to drive the demand for the product over the forecast period. In addition, increasing R&D investments by various companies for developing new diagnostic techniques and applications are anticipated to further propel growth during the study period.
Increasing adoption of these products in clinical trials across various disease categories is expected to fuel market growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, favorable reimbursement scenario, and increasing healthcare expenditure are some of the factors contributing to its growth. In addition, growing interest among patients for diagnostic procedures that use contrast media is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India and China. Moreover, an increase in awareness regarding various advanced imaging techniques will also support regional growth during the estimated time span.
Growth Factors:
- Increasing incidence of cancer and other diseases that require diagnosis and treatment using radiopharmaceuticals & contrast media
- Growing demand for minimally invasive diagnostic procedures that use radiopharmaceuticals & contrast media
- Rising number of nuclear medicine centers and clinics worldwide
- Proliferation of PET/CT scanners in hospitals and other healthcare facilities
- Technological advancements in the development of radiopharmaceuticals & contrast media
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report
By Type
Radiopharmaceuticals, Contrast Media
By Application
Hospital, Clinic, Other
By Companies
Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion, Amag Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Report Segments:
The global Diagnostic Radiopharmaceuticals & Contrast Media market is segmented on the basis of:
Types
Radiopharmaceuticals, Contrast Media
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amag Pharmaceuticals
- Bayer Healthcare
- Bracco Imaging
- Daiichi Sankyo
- GE Healthcare
- Guerbet
- Lantheus
- Mallinckrodt
- Medtronic
- Nordion
- Amag Pharmaceuticals
Highlights of The Diagnostic Radiopharmaceuticals & Contrast Media Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiopharmaceuticals
- Contrast Media
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Radiopharmaceuticals & Contrast Media Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diagnostic radiopharmaceuticals and contrast media are substances used in medical imaging to create images of the body. Diagnostic radiopharmaceuticals include x-rays, gamma rays, and other forms of radiation. Contrast media is any material that helps make an image more visible. Common types of contrast media include liquids, gels, and pastes.
Some of the major companies in the diagnostic radiopharmaceuticals & contrast media market are Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion, Amag Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diagnostic Radiopharmaceuticals & Contrast Media Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diagnostic Radiopharmaceuticals & Contrast Media Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size & Forecast, 2020-2028
4.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Size and Y-o-Y Growth
4.5.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Radiopharmaceuticals
5.2.2 Contrast Media
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Radiopharmaceuticals
9.6.2 Contrast Media
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Radiopharmaceuticals
10.6.2 Contrast Media
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Radiopharmaceuticals
11.6.2 Contrast Media
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Radiopharmaceuticals
12.6.2 Contrast Media
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Radiopharmaceuticals
13.6.2 Contrast Media
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diagnostic Radiopharmaceuticals & Contrast Media Market: Competitive Dashboard
14.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amag Pharmaceuticals
14.3.2 Bayer Healthcare
14.3.3 Bracco Imaging
14.3.4 Daiichi Sankyo
14.3.5 GE Healthcare
14.3.6 Guerbet
14.3.7 Lantheus
14.3.8 Mallinckrodt
14.3.9 Medtronic
14.3.10 Nordion
14.3.11 Amag Pharmaceuticals
